Amplitude Surgical SA
PAR:AMPLI

Watchlist Manager
Amplitude Surgical SA Logo
Amplitude Surgical SA
PAR:AMPLI
Watchlist
Price: 6 EUR -1.64% Market Closed
Market Cap: 288.1m EUR

Wall Street
Price Targets

AMPLI Price Targets Summary
Amplitude Surgical SA

There are no price targets for AMPLI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Amplitude Surgical SA Competitors:
Price Targets
7716
Nakanishi Inc
49% Upside
2235
MicroTech Medical Hangzhou Co Ltd
24% Downside
EMBLA
Embla Medical hf
36% Upside
GKOS
Glaukos Corp
106% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
4% Upside
PRN
Profound Medical Corp
253% Upside
STXS
Stereotaxis Inc
187% Upside
IDXX
IDEXX Laboratories Inc
33% Upside

Revenue
Forecast

Revenue Estimate
Amplitude Surgical SA

For the last 8 years the compound annual growth rate for Amplitude Surgical SA's revenue is 3%. The projected CAGR for the next 4 years is -5%.

3%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Amplitude Surgical SA

For the last 8 years the compound annual growth rate for Amplitude Surgical SA's operating income is 14%.

14%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Amplitude Surgical SA

For the last 8 years the compound annual growth rate for Amplitude Surgical SA's net income is 27%.

27%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
91%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMPLI's stock price target?
Not Available

AMPLI doesn't have any price targets made by Wall Street professionals.

What is Amplitude Surgical SA's Revenue forecast?
Projected CAGR
-5%

For the last 8 years the compound annual growth rate for Amplitude Surgical SA's revenue is 3%. The projected CAGR for the next 4 years is -5%.

Back to Top